Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute sulphasalazine hepatotoxicity.

P E Jennings, R L Blandford, F D Rosenthal

    Postgraduate Medical Journal
    |April 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Severe sulphasalazine hepatotoxicity, an acute hypersensitivity reaction, can be managed with supportive care alone. Drug withdrawal is key, as steroids were not needed in this case.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances.

    The British journal of radiology·2014
    Same author

    Re: Effect of visualization display colour on polyp conspicuity at virtual colonoscopy.

    Clinical radiology·2009
    Same author

    The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus.

    British journal of biomedical science·2008
    Same author

    Weight gain during the treatment of thyrotoxicosis using conventional thyrostatic treatment.

    Journal of endocrinological investigation·2008
    Same author

    Erythropoetin treatment significantly alters measured glycated haemoglobin (HbA1c).

    Diabetic medicine : a journal of the British Diabetic Association·2008
    Same author

    Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

    The Journal of clinical endocrinology and metabolism·2004

    Area of Science:

    • Hepatology
    • Clinical Pharmacology
    • Immunology

    Background:

    • Sulfasalazine is a widely used medication for inflammatory bowel disease and rheumatoid arthritis.
    • Hepatotoxicity is a rare but serious adverse effect associated with sulfasalazine therapy.
    • Hypersensitivity reactions can manifest with diverse clinical presentations, including hepatic injury.

    Observation:

    • A case of severe hepatotoxicity attributed to sulfasalazine is presented.
    • The patient exhibited clinical and biochemical features consistent with an acute hypersensitivity reaction.
    • Corticosteroids were intentionally withheld during the management of this case.

    Findings:

    • The patient's liver function normalized solely after the discontinuation of sulfasalazine.

    Related Experiment Videos

  • The absence of steroid administration did not impede recovery, suggesting a hypersensitivity-mediated mechanism.
  • Supportive treatment was sufficient for managing the drug-induced liver injury.

    • Implications:

    • This case highlights the importance of recognizing sulfasalazine-induced hepatotoxicity as a hypersensitivity phenomenon.
    • It suggests that supportive care and drug withdrawal may be adequate, potentially avoiding the need for corticosteroids.
    • Clinicians should consider sulfasalazine hepatotoxicity in patients presenting with acute liver injury, especially those on the medication.